Skip to main content
. 2020 Nov 11;12(11):1084. doi: 10.3390/pharmaceutics12111084
ROS reactive oxygen species
EMT epithelial-to-mesenchymal transition
miRNA microRNA
PI3K phosphatidylinositol 3-kinase
Akt protein kinase-B
NF-κB nuclear factor-kappaB
HCC hepatocellular carcinoma
P-gp P-glycoprotein
MDR1 multidrug resistance 1
Nrf2 nuclear factor erythroid 2-related factor 2
TGF-β1 transforming growth factor-beta 1
DOX doxorubicin
TFF3 trefoil factor 3
SphK1 sphingosine kinase 1
OS osteosarcoma
GSH glutathione
SOD superoxide dismutase
MDH malondialdehyde
ECM extracellular matrix
TIMPs tissue inhibitors of metalloproteinases
EMT epithelial-to-mesenchymal transition
ZnCM-SD curcumin-Zn solid dispersion
ABC ATP-binding cassette
ABCB4 ABC sub-family B member 4
EGCG epigallocatechin gallate
S100A8 S100 calcium-binding protein A8
AP-1 activator protein-1
CAT catalase
TNF-α tumor necrosis factor-α
IL-1β interleukin-1β
CAR carvacrol
PiC mitochondrial phosphate carrier
MSNs mesoporous silica nanoparticles
EE encapsulation efficiency
VEGF vascular endothelial growth factor
EPR enhanced permeability and retention
MDR multidrug resistance
GLUT-1 glucose transporter-1
BBB blood-brain barrier
uPAR urokinase plasminogen activator receptor
HO-1 heme oxygenase-1
NQO1 NAD(P)H dehydrogenase [quinone] 1